• Open Account

Aurobindo Pharma (ARBP IN) – Q1FY26 Result Update – Weak US sales – BUY

Published on 06 Aug 2025

Download Full Report

Other Reports

Tata Steel (TATA IN) – Event Update – Growth capex for India, but need to expediate – Accumulate

Tata Elxsi (TELX IN) – Management Meet Update – Key segment outlook improves, but broader pain continues – Upgrade to ‘HOLD’

Technical Newsletter: 15-Dec-2025
App QR Code

Download the PL Capital App